In the long term, Viking Therapeutics could reach a price of $ 75.81 in December of 2030. That's a rather optimistic scenario, as VKTX could trade as low as $ ...

18 сент. 2024 г. · Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 · 1. Moderna · 2. Vertex Pharmaceuticals · 3. Viking Therapeutics.

Viking Therapeutics Inc Stock (VKTX) is expected to reach an average price of $241.47 in 2030, with a high forecast of $335.31 and a low forecast of $147.63.

13 апр. 2024 г. · Viking Therapeutics is targeting two markets that could top $100 billion by 2030. Motley Fool Issues Rare “All In” Buy Alert · NASDAQ: CRSP.

26 авг. 2024 г. · Viking Therapeutics and CRISPR Therapeutics could be the best-performing biotechs through 2030, but they could also move in the opposite direction if things ...

11 сент. 2024 г. · The analysts forecast that Viking's anticipated oral weight-loss drug could claim about 10% of the market after its projected 2030 release.

Viking Therapeutics Stock Forecast 2026-2030 These five years would bring a significant increase: Viking Therapeutics price would move from $92.19 to $244.63, ...

Оценка 5,0 (11) The average price target is $113.67 with a high forecast of $138.00 and a low forecast of $95.00. The average price target represents a 80.03% change from the ...

The average one-year price target for Viking Therapeutics, Inc. is $115.82. The forecasts range from a low of $90.90 to a high of $144.90.

21 окт. 2024 г. · VKTX is set to report third-quarter earnings on Oct. 23, after market close. Since the company lacks a marketed drug in its portfolio, we do not expect it to ...